Barclays’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $148K | Buy |
43,028
+1,133
| +3% | +$3.9K | ﹤0.01% | 3683 |
|
|
2025
Q1 | $94K | Buy |
41,895
+3,544
| +9% | +$7.95K | ﹤0.01% | 3711 |
|
|
2024
Q4 | $112K | Buy |
38,351
+16,058
| +72% | +$46.9K | ﹤0.01% | 3770 |
|
|
2024
Q3 | $58K | Buy |
22,293
+1,465
| +7% | +$3.81K | ﹤0.01% | 3878 |
|
|
2024
Q2 | $62K | Sell |
20,828
-151,530
| -88% | -$451K | ﹤0.01% | 3588 |
|
|
2024
Q1 | $780K | Buy |
172,358
+51,701
| +43% | +$234K | ﹤0.01% | 2575 |
|
|
2023
Q4 | $689K | Buy |
120,657
+99,671
| +475% | +$569K | ﹤0.01% | 2830 |
|
|
2023
Q3 | $97K | Sell |
20,986
-504,978
| -96% | -$2.33M | ﹤0.01% | 3340 |
|
|
2023
Q2 | $3.4M | Buy |
525,964
+5,443
| +1% | +$35.2K | ﹤0.01% | 1448 |
|
|
2023
Q1 | $3.93M | Buy |
520,521
+203,493
| +64% | +$1.53M | ﹤0.01% | 1222 |
|
|
2022
Q4 | $3.21M | Buy |
317,028
+80,630
| +34% | +$817K | ﹤0.01% | 1361 |
|
|
2022
Q3 | $2.34M | Sell |
236,398
-4,830
| -2% | -$47.8K | ﹤0.01% | 1550 |
|
|
2022
Q2 | $2.57M | Sell |
241,228
-6,842
| -3% | -$72.9K | ﹤0.01% | 1419 |
|
|
2022
Q1 | $2.42M | Buy |
+248,070
| New | +$2.42M | ﹤0.01% | 1642 |
|